Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The British Society for Antimicrobial Chemotherapy (BSAC) is an influential professional organization and registered charity dedicated to the study and effective use of antimicrobial agents. Founded in 1971, the society supports a global network of specialists through education, research funding, and the publication of high-impact journals, including the Journal of Antimicrobial Chemotherapy (JAC). BSAC plays a critical role in the global fight against antimicrobial resistance (AMR) by providing clinical guidelines, surveillance data, and advocacy for better antibiotic stewardship. The organization also hosts international conferences and offers extensive online learning resources to healthcare professionals worldwide. Its work is essential for informing clinical practice and policy in the field of infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on British Society for Antimicrobial Chemotherapy.